SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

MSR India gains on increasing stake in Farmax India

12 Feb 2014 Evaluate

MSR India is currently trading at Rs. 29.00, up by 0.55 points or 1.93% from its previous closing of Rs. 28.45 on the BSE.

The scrip opened at Rs. 29.60 and has touched a high and low of Rs. 29.60 and Rs. 29.00 respectively. So far 3351 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 5 has touched a 52 week high of Rs. 63.00 on 13-Jun-2013 and a 52 week low of Rs. 16.80 on 10-Dec-2013.

Last one week high and low of the scrip stood at Rs. 30.30 and Rs. 26.85 respectively. The current market cap of the company is Rs. 182.35 crore.

The promoters holding in the company stood at 71.05 % while Institutions and Non-Institutions held NA % and 28.95 % respectively.

MSR India has acquired 20.4 million shares of Farmax India. Recently, Credit rating agency, CARE had reaffirmed D rating to Farmax India’s Long-term Bank Facilities worth Rs 108.49 crore and D rating to Short-term Bank Facilities worth Rs 2.00 crore. The ratings continue to take into account the delays in servicing of debt obligations.

Farmax India is engaged in the business of manufacturing and marketing of fast moving consumer goods. It has a manufacturing facility with advanced technology imported (machinery is one of the highly sophisticated in that category and was imported from Italian food Major) and indigenous automated machines to meet quality consistency and  market demand with minimum manufacturing cost resulting affordable finished product cost with consisted quality.

MSR Copper Share Price

5.81 -0.11 (-1.86%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindalco 1038.95
Vedanta 787.60
Hindustan Zinc 592.35
Jain Resource Recycl 420.90
Gravita India 1639.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×